{"id":529,"date":"2019-03-25T09:00:00","date_gmt":"2019-03-25T09:00:00","guid":{"rendered":"https:\/\/isosolution-v2.staging.xiyx.ai\/news\/evaluation-of-111in-dota-5d3-a-surrogate-spect-imaging-agent-for-radioimmunotherapy-of-prostate-specific-membrane-antigen\/"},"modified":"2019-03-25T09:00:00","modified_gmt":"2019-03-25T09:00:00","slug":"evaluation-of-111in-dota-5d3-a-surrogate-spect-imaging-agent-for-radioimmunotherapy-of-prostate-specific-membrane-antigen","status":"publish","type":"iso_news","link":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/news\/evaluation-of-111in-dota-5d3-a-surrogate-spect-imaging-agent-for-radioimmunotherapy-of-prostate-specific-membrane-antigen\/","title":{"rendered":"\u00c9valuation de 111In-DOTA-5D3, un agent d'imagerie SPECT substitutif pour la radioimmunoth\u00e9rapie de l'antig\u00e8ne membranaire sp\u00e9cifique \u00e0 la prostate"},"content":{"rendered":"<p>5D3 est un nouvel anticorps monoclonal murin de haute affinit\u00e9 sp\u00e9cifique \u00e0 l'antig\u00e8ne membranaire sp\u00e9cifique \u00e0 la prostate (PSMA). La LMFP est une cible pour l'imagerie et le traitement du cancer de la prostate. 111Des anticorps sous \u00e9tiquette ont \u00e9t\u00e9 utilis\u00e9s comme substituts pour des traitements marqu\u00e9s 177Lu\/90Y. Nous avons caract\u00e9ris\u00e9 111In-DOTA-5D3 par imagerie SPECT\/CT, \u00e9tudes de biodistribution tissulaire et dosim\u00e9trie.<br \/>\n <a href=\"https:\/\/isosolutions.com\/evaluation-of-111in-dota-5d3\/\"><span aria-label=\"Continuer la lecture \u00c9valuation de 111In-DOTA-5D3, un agent d&#039;imagerie SPECT substitutif pour la radioimmunoth\u00e9rapie de l&#039;antig\u00e8ne membranaire sp\u00e9cifique \u00e0 la prostate\">(plus...)<\/span><\/a><\/p>\n<\/p><\/div>\n<p>\u00c9tiquettes : <a href=\"https:\/\/isosolutions.com\/news-tag\/immunoimaging\/\" rel=\"tag\">immuno-imagerie<\/a> <a href=\"https:\/\/isosolutions.com\/news-tag\/monoclonal-antibody\/\" rel=\"tag\">anticorps monoclonaux<\/a> <a href=\"https:\/\/isosolutions.com\/news-tag\/prostate-cancer\/\" rel=\"tag\">cancer de la prostate<\/a> <a href=\"https:\/\/isosolutions.com\/news-tag\/psma\/\" rel=\"tag\">LMFP<\/a> <a href=\"https:\/\/isosolutions.com\/news-tag\/spect\/\" rel=\"tag\">SPECT<\/a> <a href=\"https:\/\/isosolutions.com\/news-tag\/spect-ct\/\" rel=\"tag\">SPECT\/CT<\/a><\/p>\n<\/p><\/div>","protected":false},"excerpt":{"rendered":"<p>5D3 is a new high-affinity murine monoclonal antibody specific for prostate-specific membrane antigen (PSMA). PSMA is a target for the imaging and therapy of prostate cancer. 111In-labeled antibodies\u2026<\/p>","protected":false},"featured_media":557,"template":"","iso_news_section":[43],"class_list":["post-529","iso_news","type-iso_news","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/wp-json\/wp\/v2\/iso_news\/529","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/wp-json\/wp\/v2\/iso_news"}],"about":[{"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/wp-json\/wp\/v2\/types\/iso_news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/wp-json\/wp\/v2\/media\/557"}],"wp:attachment":[{"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/wp-json\/wp\/v2\/media?parent=529"}],"wp:term":[{"taxonomy":"iso_news_section","embeddable":true,"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/fr\/wp-json\/wp\/v2\/iso_news_section?post=529"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}